國立虎尾科技大學 |

Colon Cancer Diagnosis and Therapy Vol. 3

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Colon Cancer Diagnosis and Therapy Vol. 3/ edited by Dhananjay Shukla, Naveen Kumar Vishvakarma, Ganji Purnachandra Nagaraju.
other author:	Shukla, Dhananjay.
Description:	XVI, 460 p. 38 illus., 32 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Cancer—Treatment. -
Online resource:	https://doi.org/10.1007/978-3-030-72702-4
ISBN:	9783030727024

Colon Cancer Diagnosis and Therapy Vol. 3
Colon Cancer Diagnosis and Therapy Vol. 3[electronic resource] /edited by Dhananjay Shukla, Naveen Kumar Vishvakarma, Ganji Purnachandra Nagaraju. - 1st ed. 2022. - XVI, 460 p. 38 illus., 32 illus. in color.online resource.

Chapter 1. Role of chemokines in colorectal cancer -- Chapter 2. Extracellular vesicles in colorectal cancer growth, metastasis, diagnosis and therapy -- Chapter 3. Epigenetic regulation of colorectal cancer (CRC) -- Chapter 4. Mechanistic exploration and therapeutic management of colon cancer metastasis -- Chapter 5. Chemoresistance in colon malignancies -- Chapter 6. Targeting pathogenic inflammation for therapeutic intervention against colon cancer -- Chapter 7. Role of tumor associated macrophages in colon cancer progression and its therapeutic targeting -- Chapter 8. Therapeutic intervention of signaling pathways in colorectal cancer -- Chapter 9. Advances in chemoradiotherapy for treatment of colon cancer -- Chapter 10. Cytotoxic and chemopreventive activity of polyphenols and their derivatives in colon cancer -- Chapter 11. Prevention and management of colon cancer by nutritional intervention -- Chapter 12. Development of RNA based medicine for colorectal cancer -- Chapter 13. Role of food additives and intestinal microflora in colorectal cancer -- Chapter 14. Probiotics in colon cancer -- Chapter 15. Bacterial cancer therapy -- Chapter 16. Antineoplastic effects of curcumin against colorectal cancer -- Chapter 17. Cyanobacterial secondary metabolite -- Chapter 18. Clinical significance of genetic variants in colon cancer.

Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the third of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutics, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.

ISBN: 9783030727024

Standard No.: 10.1007/978-3-030-72702-4doiSubjects--Topical Terms:

1389304
Cancer—Treatment.

LC Class. No.: RC270.8

Dewey Class. No.: 616.994

Colon Cancer Diagnosis and Therapy Vol. 3
LDR:04026nam a22003855i 4500 001 1094219
003 DE-He213
005 20220214044728.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030727024 $9 978-3-030-72702-4
024 7 $a 10.1007/978-3-030-72702-4 $2 doi
035 $a 978-3-030-72702-4
050 4 $a RC270.8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Colon Cancer Diagnosis and Therapy Vol. 3 $h [electronic resource] / $c edited by Dhananjay Shukla, Naveen Kumar Vishvakarma, Ganji Purnachandra Nagaraju.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XVI, 460 p. 38 illus., 32 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Role of chemokines in colorectal cancer -- Chapter 2. Extracellular vesicles in colorectal cancer growth, metastasis, diagnosis and therapy -- Chapter 3. Epigenetic regulation of colorectal cancer (CRC) -- Chapter 4. Mechanistic exploration and therapeutic management of colon cancer metastasis -- Chapter 5. Chemoresistance in colon malignancies -- Chapter 6. Targeting pathogenic inflammation for therapeutic intervention against colon cancer -- Chapter 7. Role of tumor associated macrophages in colon cancer progression and its therapeutic targeting -- Chapter 8. Therapeutic intervention of signaling pathways in colorectal cancer -- Chapter 9. Advances in chemoradiotherapy for treatment of colon cancer -- Chapter 10. Cytotoxic and chemopreventive activity of polyphenols and their derivatives in colon cancer -- Chapter 11. Prevention and management of colon cancer by nutritional intervention -- Chapter 12. Development of RNA based medicine for colorectal cancer -- Chapter 13. Role of food additives and intestinal microflora in colorectal cancer -- Chapter 14. Probiotics in colon cancer -- Chapter 15. Bacterial cancer therapy -- Chapter 16. Antineoplastic effects of curcumin against colorectal cancer -- Chapter 17. Cyanobacterial secondary metabolite -- Chapter 18. Clinical significance of genetic variants in colon cancer.
520 $a Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the third of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutics, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.
650 0 $a Cancer—Treatment. $3 1389304
650 0 $a Cancer. $3 581034
650 0 $a Medical screening. $3 789403
650 0 $a Immunotherapy. $3 592896
650 0 $a Biochemical markers. $3 582469
650 1 4 $a Cancer Therapy. $3 1389305
650 2 4 $a Cancer Screening. $3 1402335
650 2 4 $a Biomarkers. $3 1155103
700 1 $a Shukla, Dhananjay. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1360375
700 1 $a Vishvakarma, Naveen Kumar. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1360374
700 1 $a Nagaraju, Ganji Purnachandra. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1198408
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030727017
776 0 8 $i Printed edition: $z 9783030727031
856 4 0 $u https://doi.org/10.1007/978-3-030-72702-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)